Summary
Two studies were performed to investigate acute and chronic organ toxicity after Mitomycin C (MMC) administration in Wistar rats. Six rats received 2.5 mg/kg MMC i.p. once and were followed for 5 consecutive days. The alanine aminopeptidase (AAP)/creatinine ratio increased significantly, compared to a control group receiving saline. Four groups of rats were injected i.p. weekly for 5 weeks; 6 control rats with saline, 7 rats with 1.7 mg/kg of MMC, 7 rats with 10 mg/kg 5-fluorouracil (5-FU) and 7 rats with MMC as well as 5-FU. The latter two groups were included to study possible toxicity synergism between the two drugs. A significant decrease in AAP excretion in the MMC group, as well as a nonsignificant decrease in the MMC/5-FU group were the most remarkable observations. Light microscopy did not show renal changes, but did show alveolar septal congestion after repeated MMC injections. It is concluded that MMC causes tubular damage in Wistar rats, with acute leakage of enzyme from the cells, followed by enzyme depletion during chronic treatment. Also MMC induces pulmonary changes in Wistar rats. To what extent these changes represent early stages of toxicity remains to be elucidated.
Similar content being viewed by others
References
Burchardt U, Peters JE, Neef L, Thulin H, Grundig CA, Haschen RJ (1977) Der diagnostische Wert von Enzymbestimmungen im Harn. Z Med Lab Diagn 18:190–212
Buzdar AU, Legha SW, Tashima ChK, Hortobagyi GN, Yap HY, Krutchik AM, Luna MA, Blumenschein GR (1978) Adriamycin and Mitomycin C: possible synergistic cardiotoxicity. Cancer Treat Rep 62:1005–1008
Cattell V (1985) Mitomycin-induced hemolytic uremic kidney. An experimental model in the rat. Am J Pathol 121:88–95
Creech RH, Catalano RB, Shah MK, Dayal H (1983) An effective low-dose mitomycin regimen for hormonal-and chemotherapy-refractory patients with metastatic breast cancer. Cancer 51:1034–1040
Dance N, Price RG, Robinson D, Stirling JL (1969) Galactosidase, β-glucosidase and N-acetyl-β-glucosaminidase in human kidney. Clin Chim Acta 24:189–197
Diener U, Knoll E, Langer B, Rautenstrauch H, Ratge D, Wisser H (1981) Urinary excretion of N-acetyl-β-d-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum. Clin Chim Acta 112:149–157
Fujita H (1971) Comparative studies on the blood level, tissue distribution, excretion and inactivation of anticancer drugs Jpn J Clin Oncol 12:151–162
Gibey R, Dupond JL, Alber D, Leconte des Floris R, Henry JC (1981) Predictive value of urinary N-acetyl-β-d-glucosaminidase (NAG), alanine aminopeptidase (AAP) and B2-microglobulin (B2M) in evaluating nephrotoxicity of gentamycin. Clin Chim Acta 116:24–34
Johnston IDA, Jones NF, Scoble JE, Yuen CT, Price RG (1983) The diagnostic value of urinary enzyme measurements in hypertension. Clin Chim Acta 133:317–325
Kunin CM, Chesney RW, Craig WA (1978) Enzymuria as a marker of renal injury and disease: studies of N-acetyl-β-glucosaminidase in the general population and in patients with renal disease. Pediatrics 62:751–760
Kuroda K, Teranishi S, Akao M (1982) Toxicity of Mitomycin C and anti-intoxication by fumaric acid in liver and kidney cellular fine structure. Gann 73:656–660
Le Hir M, Dubach UC, Schmidt U (1979) Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry 63:245–251
Levillain R, Cluzan R (1973) Cardiac toxicity of antimitotic drugs. Proc 3rd Meeting EACR, p 100
Matsuyama M, Suzumori K, Nakamura T (1964) Biological studies of anti-cancer agents. I. Effects of prolonged intraperitoneal injections of mitomycin C on the urinary organs. J Urol 92:618–620
Mattenheimer H (1977) Enzymes in renal disease. Am Clin Lab Sci 7:422–432
Mondorf AW (1982) Enzymologie der Niere. In: Losse H, Renner E (eds) Klinische Nephrologie. Thieme, Stuttgart, S 123–129
Mondorf AW, Kinne R, Scherberich JE, Falkenberg F (1972) Isolierung enzymatische und immunologische Charakterisierung einer Plasmamembranfraktion von proximalen Tubulus der menschlichen Niere. Clin Chim Acta 37:25–32
Orwoll ES, Kiessling PJ, Patterson JR (1978) Interstitial pneumonia from mitomycin. Ann Int Med 89:352–355
Peters JE, Schneider I, Haschen RJ (1972) Bestimmung der l-alanyl-peptidhydrolase (Alaninamiopeptidase, Aminosaurearylamidase) im menschlichen Harn. Clin Chim Acta 36:289–301
Philips FS, Schwartz HS, Sternberg SS (1960) Pharmacology of mitomycin C. I. Toxicity and pathologic effects. Cancer Res 20:1354–1361
Price RG, Dance N (1967) The cellular distribution of some rat and kidney glycosidases. Biochem J 105:877–883
Robinson D, Price RG, Dance N (1967) Separation and properties of β-galactosidase, β-glucosidase, β-glucuronidase, and N-acetyl-β-glucosaminidase from rat kidney. Biochem J 192:525–532
Roth M (1964) Une ultramicro methode fluoromethique pour le dosage de la leucine aminopeptidase dans les liquides biologiques. Clin Chim Acta 9:448
Scherberich JE, Falkenberg F, Mondorf AW, Muller H, Pfleiderer G (1974) Biochemical and immunological studies on isolated brush border membranes of human kidney and their membrane surface proteins. Clin Chim Acta 45:179–197
Sherman RL, Drayer DE, Leyland-Jones BR, Reidenberg MM (1983) N-acetyl-β-glucosaminidase and β2-microglobulin. Arch Int Med 143:1183–1185
Suzuki Y, Nübe H (1975) Radiation-indiced heart injury: radiopathological study. Kita Kanto Igaku 25:395–407
Verweij J, Boven E, van der Meulen J, Pinedo HM (1984) Recovery from mitomycin C-induced hemolytic uremic syndrome. A case report. Cancer 54:2878–2881
Wellwood JM, Ellis BG, Price RG, Hammond K, Thompson AE, Jones NF (1975) Urinary N-acetyl-β-d-glucosaminidase activities in patients with renal disease. Br Med J 3:408–411
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verweij, J., Kerpel-Fronius, S., Stuurman, M. et al. Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney. J Cancer Res Clin Oncol 114, 137–141 (1988). https://doi.org/10.1007/BF00417827
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00417827